Cargando…

The Nanotechnology-Based Approaches against Kirsten Rat Sarcoma-Mutated Cancers

Kirsten rat sarcoma (KRAS) is a small GTPase which acts as a molecular switch to regulate several cell biological processes including cell survival, proliferation, and differentiation. Alterations in KRAS have been found in 25% of all human cancers, with pancreatic cancer (90%), colorectal cancer (4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrade, Fernanda, German-Cortés, Júlia, Montero, Sara, Carcavilla, Pilar, Baranda-Martínez-Abascal, Diego, Moltó-Abad, Marc, Seras-Franzoso, Joaquín, Díaz-Riascos, Zamira Vanessa, Rafael, Diana, Abasolo, Ibane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302894/ https://www.ncbi.nlm.nih.gov/pubmed/37376135 http://dx.doi.org/10.3390/pharmaceutics15061686

Ejemplares similares

Pivotal Role of AKT2 during Dynamic Phenotypic Change of Breast Cancer Stem Cells
por: Gener, Petra, et al.
Publicado: (2019)

Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide
por: Cámara-Sánchez, Patricia, et al.
Publicado: (2022)

Extracellular Vesicles as Drug Delivery Systems in Cancer
por: Hernandez-Oller, Laia, et al.
Publicado: (2020)

Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
por: Ulldemolins, Anna, et al.
Publicado: (2021)

Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells
por: Gener, Petra, et al.
Publicado: (2018)

Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells
por: Montero, Sara, et al.
Publicado: (2020)

Extracellular vesicles from recombinant cell factories improve the activity and efficacy of enzymes defective in lysosomal storage disorders
por: Seras‐Franzoso, Joaquin, et al.
Publicado: (2021)

AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells
por: Rafael, Diana, et al.
Publicado: (2018)

Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies
por: Pesarrodona, Mireia, et al.
Publicado: (2019)

Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment
por: German-Cortés, Júlia, et al.
Publicado: (2023)

Effect of pseudotype on Abelson virus and Kirsten sarcoma virus-induced leukemia
Publicado: (1978)

Sterilization Procedure for Temperature-Sensitive Hydrogels Loaded with Silver Nanoparticles for Clinical Applications
por: Rafael, Diana, et al.
Publicado: (2019)

Kirsten rat sarcoma virus protein overexpression in adenocarcinoma lung: Association with clinicopathological and histomorphological features
por: Pandey, Rahul Kumar, et al.
Publicado: (2020)

Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation
por: Luengo, Yurena, et al.
Publicado: (2022)

Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs
por: Céspedes, María Virtudes, et al.
Publicado: (2016)

MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation
por: Wang, Yuan, et al.
Publicado: (2015)

Computational Screening and Analysis of Lung Cancer Related Non-Synonymous Single Nucleotide Polymorphisms on the Human Kirsten Rat Sarcoma Gene
por: Wang, Qiankun, et al.
Publicado: (2019)

Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis
por: Lin, Zhizun, et al.
Publicado: (2021)

Predicting Kirsten Rat Sarcoma Virus Gene Mutation Status in Patients With Colorectal Cancer by Radiomics Models Based on Multiphasic CT
por: Hu, Jianfeng, et al.
Publicado: (2022)

Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes
por: Cano-Garrido, Olivia, et al.
Publicado: (2015)

Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study
por: Andreyev, H J N, et al.
Publicado: (2001)

Kirsten Ras* oncogene: Significance of its discovery in human cancer research
por: Tsuchida, Nobuo, et al.
Publicado: (2016)

Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses
Publicado: (1986)

Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer
por: Hamilton, Gerhard, et al.
Publicado: (2023)

Solitary acrometastasis of the phalanx as initial presentation of an oligometastatic Kirsten rat sarcoma viral oncogene homolog-mutated lung adenocarcinoma: a case report
por: Pușcașu, Alexandra-Ioana, et al.
Publicado: (2023)

Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste
por: Unzueta, Ugutz, et al.
Publicado: (2022)

Inhibition of lung adenocarcinoma cells by insulin-like growth factor-I receptor and Kirsten rat sarcoma mutations: A mutation analysis with antisense oligodeoxynucleotide
por: Li, Shaoming, et al.
Publicado: (2015)

Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives
por: Li, Jia-Xin, et al.
Publicado: (2022)

Complete response to nivolumab in Kirsten rat sarcoma virus oncogene KRAS-G12C mutant metastatic lung adenocarcinoma: a case report
por: Boby, Jeffrey Mathew, et al.
Publicado: (2022)

Kirsten murine sarcoma virus abolishes interferon gamma-induced class II but not class I major histocompatibility antigen expression in a murine fibroblast line
Publicado: (1988)

Normal Human Chromosome 1 Carries Suppressor Activity for Various Phenotypes of a Kirsten Murine Sarcoma Virus‐transformed NIH/3T3 Cell Line
por: Yamada, Hideto, et al.
Publicado: (1990)

The emerging role of cancer nanotechnology in the panorama of sarcoma
por: Mercatali, Laura, et al.
Publicado: (2022)

Discovering and Targeting Dynamic Drugging Pockets of Oncogenic Proteins: The Role of Magnesium in Conformational Changes of the G12D Mutated Kirsten Rat Sarcoma-Guanosine Diphosphate Complex
por: Hu, Zheyao, et al.
Publicado: (2022)

Isolation of cell-free bacterial inclusion bodies
por: Rodríguez-Carmona, Escarlata, et al.
Publicado: (2010)

Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations
por: Li, Meng, et al.
Publicado: (2019)

Cortical bone histomorphology of known‐age skeletons from the Kirsten collection, Stellenbosch university, South Africa
por: Pfeiffer, Susan, et al.
Publicado: (2016)

The regulatory G4 motif of the Kirsten ras (KRAS) gene is sensitive to guanine oxidation: implications on transcription
por: Cogoi, Susanna, et al.
Publicado: (2018)

Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
por: Torrealba, Débora, et al.
Publicado: (2016)

Role of Poly [ADP-ribose] Polymerase 1 in Activating the Kirsten ras (KRAS) Gene in Response to Oxidative Stress
por: Cinque, Giorgio, et al.
Publicado: (2020)

Application of novel nanotechnologies in asthma
por: da Silva, Adriana Lopes, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_44g44qtjaf6ri653llpe55u6o8